Related Experiment Videos
Pediatric heart transplantation without chronic maintenance steroids
P Ferrazzi1, R Fiocchi, A Gamba
1Department of Cardiac Surgery, Ospedali Riuniti di Bergamo, Italy.
Summary
Pediatric heart transplantation achieved an 88% 5-year survival rate, with no deaths from rejection or infection. This study highlights successful outcomes in young heart transplant recipients.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Immunosuppression Therapy
Background:
- Heart transplantation in children is a critical treatment for end-stage heart failure.
- Indications vary, including cardiomyopathy and congenital heart disease.
- Optimizing immunosuppression and managing complications are key challenges.
Purpose of the Study:
- To evaluate the outcomes of pediatric heart transplantation.
- To assess survival rates, rejection episodes, infections, and long-term complications.
- To analyze growth and graft atherosclerosis in pediatric recipients.
Main Methods:
- Retrospective analysis of 40 pediatric heart transplant recipients (aged 2 months to 18 years) from 1986 to 1993.
- Management with cyclosporine and azathioprine, with selective steroid use for rejection.
- Monitoring included noninvasive methods for younger children, annual catheterizations, and growth assessments.
Main Results:
- Overall 5-year survival was 88%, with no deaths attributed to rejection or infection.
- Rejection treatment was common in the first postoperative month (89%).
- Graft atherosclerosis was not observed; growth was not impaired compared to controls. Seizures and hypertension were noted in some patients.
Conclusions:
- Pediatric heart transplantation demonstrates favorable long-term survival and acceptable complication rates.
- Current immunosuppressive strategies appear effective in preventing fatal rejection and infection.
- Further research on long-term graft health and neurodevelopmental outcomes is warranted.